Evidence map›Paper›PMID 40705144›Full record

ArticleMedical oncology (Northwood, London, England)2025

ROCK inhibition suppresses glioblastoma via a PTEN-associated reduction in PI3K/AKT signaling.

Ebru Uzunhisarcıklı, Nuh Mehmet Bozkurt, Ayşe Sağlam

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ebru UzunhisarcıklıFaculty of Pharmacy, Pharmacology Department, Erciyes University, Kayseri, Turkey. ebruozturk@erciyes.edu.tr.ORCID http://orcid.org/0000-0002-7088-7490
Nuh Mehmet BozkurtFaculty of Pharmacy, Pharmacology Department, Erciyes University, Kayseri, Turkey.
Ayşe SağlamPharmacology Department, Institute of Health Sciences, Erciyes University, Kayseri, Turkey.

Funding

Erciyes University Scientific Research Projects Coordination Unit THD-2024-13594
6 · The paper itself

Abstract

Glioblastoma is the most common primary malignant brain tumor. It is aimed to elucidate the role of ROCK in the regulation of PI3K signaling inhibited by PTEN and to evaluate the effects of ROCK inhibitors Thiazovivin and GSK 429286 on glioblastoma as a new therapeutic strategy. U87 MG and L929 cell lines were used to research the cytotoxic effect of ROCK inhibitors Thiazovivin and GSK 429286. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method and xCELLigence real-time cell analyzer were used to determine its effect on cell viability. To assess the impact of ROCK inhibitors on PTEN protein levels, PTEN expression in cell lysates was quantitatively determined in vitro using the PTEN ELISA Kit. Total protein concentration was measured using the BCA protein assay kit, p-Akt and PTEN protein level was determined by the western blot method. Showed that GSK 429286 and Thiazovivin significantly reduced U87 MG cell viability even at low concentrations. When IC

Indexed as

Brain NeoplasmsGlioblastomaPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN Phosphohydrolaserho-Associated KinasesCell Line, TumorCell SurvivalHumansIndazolesSignal TransductionSulfonamidesThiazoles2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidineIndazolesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanrho-Associated KinasesSulfonamidesThiazolesCytotoxicityPTENThiazovivinxCELLigence

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.